CF
44
-4
ADP
55
-3
UAL
63
-9
SJM
14
-7
BSX
62
-6
GWW
46
-9
FE
30
-2
DLTR
44
-4
GOOGL
58
-8
BRK.B
17
-5
AEE
45
-5
SNA
52
-6
WDC
38
-4
VFC
54
-7
TJX
51
-7
KMB
25
-3
CMA
39
-4
AAP
27
-3
NWSA
65
-8
DVA
59
-2
CF
44
-4
ADP
55
-3
UAL
63
-9
SJM
14
-7
BSX
62
-6
GWW
46
-9
FE
30
-2
DLTR
44
-4
GOOGL
58
-8
BRK.B
17
-5
AEE
45
-5
SNA
52
-6
WDC
38
-4
VFC
54
-7
TJX
51
-7
KMB
25
-3
CMA
39
-4
AAP
27
-3
NWSA
65
-8
DVA
59
-2
Financhill
Back

TG Therapeutics Quote, Financials, Valuation and Earnings

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54

TGTX
TG Therapeutics

Last Price:
30.97
Seasonality Move:
63.62%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

TG Therapeutics Price Quote

$30.97
-0.09 (-0.29%)
(Updated: December 19, 2024 at 10:50 AM ET)

TG Therapeutics Key Stats

Buy
54
TG Therapeutics (TGTX) is a Buy
Day range:
$30.41 - $33.90
52-week range:
$12.84 - $36.84
Dividend yield:
0%
P/E ratio:
373.00
P/S ratio:
19.73
P/B ratio:
27.19%
Volume:
2.5M
Avg. volume:
3.2M
1-year change:
70.75%
Market cap:
$5.2B
Revenue:
$233.7M
EPS:
$-0.11

How Much Does TG Therapeutics Make?

Is TG Therapeutics Growing As A Company?

  • What Is TG Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.49%
  • What Is TG Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.97%

TG Therapeutics Stock Price Performance

  • Did TG Therapeutics Stock Go Up Last Month?
    TG Therapeutics share price went up by 4.9% last month
  • Did TGTX's Share Price Rise Over The Last Year?
    TGTX share price rose by 70.75% over the past 1 year

What Is TG Therapeutics 52-Week High & Low?

TG Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy TG Therapeutics?

  • How Much Debt Does TG Therapeutics Have?
    Total long term debt quarterly is $244.2M
  • How Much Cash Does TG Therapeutics Have?
    Cash and short term investments quarterly total is $341M
  • What Is TG Therapeutics’s Book Value Per Share?
    Book value per share is 1.23

Is TG Therapeutics Cash Flow Positive?

  • What Is TGTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$28.1M
  • What Is TG Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $134.6M
  • What Is TG Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$61.6M

TG Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    TGTX return on invested capital is -4.78%
  • What Is TG Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -3.55%
  • What Is TGTX Return On Equity?
    ROE is a measure of profitability and is -8.4%

TG Therapeutics Earnings Date & Stock Price

TG Therapeutics Competitors

  • Who Are TG Therapeutics's Competitors?
    Below is a list of companies who compete with TG Therapeutics or are related in some way:
    • NovaBay Pharmaceuticals Inc (NBY)
    • Organon & Co (OGN)
    • Rhythm Pharmaceuticals Inc (RYTM)
    • Warby Parker Inc (WRBY)
    • Zoetis Inc (ZTS)

TG Therapeutics Dividend Yield

TG Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: -97.26% -40.92%
Revenue: -49.41% 2.66%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 40.75
Upside from Last Price: 31.2%

Major Shareholders

  • How many TGTX shares are owned by institutional investors?
    166.1M TGTX shares are owned by institutional investors
  • How many TGTX shares are owned by insiders?
    22M TGTX shares are owned by insiders